News in Brief Galderma showcases Alluzience with UK launch event

On March 9, pharmaceutical company Galderma welcomed guests to the highly-anticipated launch of its new liquid neuromodulator Alluzience.

The evening showcased the company’s latest development, with top Galderma key opinion leaders presenting short talks about the new neuromodulator. Plastic surgery registrar Miss Priyanka Chadha expanded on the innovation of Alluzience, including its improvement on patient psychological wellbeing, its ease of use with ready-to-use liquid formulation and the fact that it has no animal or human derived excipients.

Nurse prescriber Alice Henshaw discussed the product’s precision, whilst aesthetic practitioner Dr Kuldeep Minocha looked into the performance and safety. A large quantity of evidence from clinical studies was used throughout the talks, demonstrating high patient satisfaction and the safety and tolerability of the product, as well as its adverse events and contraindications for use.

The final talk was presented by aesthetic practitioner Dr Yusra Al-Mukhtar who noted the importance of patients’ psychological wellbeing, complete with a video of patients sharing their personal experiences of how aesthetic treatments helped them regain confidence.

Rene Wipperich, general manager at Galderma, said, “We are very proud to have launched our new product in London – it was our pleasure to see the great interest in our innovation. Our launch meeting was attended by more than 250 healthcare practitioners in-person, as well as watched online. Galderma will continue its commitment to bring new scientific solutions to our customers and drive innovation in the future.”

On the Scene

Official launch of PLIM in London

Aesthetic service provider PLIM has officially launched in the UK with an event at the Mandarin Oriental Hotel, London. The event invited guests to hear from the company’s founder Nada Ali Redha about the new technology and why she decided to launch the company to the aesthetics community. Afterwards, PLIM’s chief financial officer Anuj Saxena showed a demonstration of the easy-to use platform.

Patients are able to create a profile and upload their ID onto the PLIM Marketplace. Partner clinics and their treatments will be listed so patients can browse, book and request their preferred buy now, pay later plan. Clinics’ patients will then pay PLIM via the chosen instalment plan after receiving treatments. After the demonstration, guests heard from two clinics that have been using the technology, noting a growth in patient demand and returning patients from the instalment scheme. Guests were then invited to ask questions and speak to the team directly about the new platform. For the future, PLIM hopes to introduce eight- and 12-month instalment plans for patients to choose from, as well as expanding its platform to Switzerland and the United Arab Emirates. Ali Redha commented, “It’s amazing to see the plans and vision coming to life. Everyone at PLIM is really excited for this project to take form, bringing these services to the UK. We want accessibility to be prevalent in every part of the journey for both partner clinics and their patients.”

Wigmore

Medical

Presents announces packed line-up

Wigmore Medical Presents educational meeting returns on April 29-30 at the Royal College of Physicians, London. The two days will provide content streams on injectables, devices and skincare, as well as a full-day agenda from the International College of Aesthetic Nurses and workshop sessions from top brands. Industry-leading speakers include Dr Zein Obagi, Dr David Eccleston, Professor Syed Haq, Dr Steven Land and Julie Scott.

Evolus continues expansion in Europe

Medical aesthetic company Evolus is furthering its reach into the European market as botulinum toxin Nuceiva is now commercially available in Germany and Austria. Nuceiva has been approved by the European Commission for temporary improvement of glabellar lines. David Moatazedi, president and CEO of Evolus, said, “We are excited to introduce Nuceiva to customers in the second largest aesthetic toxin market in Europe. Entering this dynamic European market is the latest in a series of geographical expansion milestones that will help fuel Evolus above market average growth.”

Circa Skin UK partners with Platform20

Aesthetic distribution company Circa Skin UK Ltd has unveiled its partnership with Platform20 Medical Services Ltd to share its medical aesthetic products with Irish and Northern Irish practitioners. Platform20 will be responsible for the KYSENSE dermal filler and WOW facial brands in Ireland and Northern Ireland. Claire Williams, CEO of Circa Skin Ltd, says, “We are thrilled to be launching this advancement in aesthetic technology in Ireland alongside a forward-thinking company such as Platform20.”

Celluma expands global headquarters

BioPhotas Inc., the manufacturer of the Celluma SERIES of light therapy devices, has announced its global headquarters are to move from Anaheim to a larger location in Tustin, California. According to the company, the location’s 25,000 square feet of office and warehouse space will allow BioPhotas to streamline shipping operations as the company grows. Patrick Johnson, chief executive officer of BioPhotas, said, “We are very excited to be moving into a new corporate headquarters that is two and a half times larger than our current facilities.”